In a major safety advisory, the FDA discouraged surgeons from using a powered cutting tool to remove uterine fibroids. Isaac Schiff, chair of the Department of Obstetrics, Gynecology and Reproductive Biology at Massachusetts General Hospital; Robert Barbieri, chair of the Department of Obstetrics, Gynecology and Reproductive Biology at Brigham and Women’s Hospital; and Hooman Noorchashm, lecturer on surgery at Brigham and Women’s Hospital, are quoted. The agency’s review was prompted by media coverage of the case of Amy Reed, instructor in anaesthesia at Beth Israel Deaconess Medical Center.
